As seen on:
As seen on:
Latest Articles
This week’s Smart Reads features long-term dividend ideas, blue-chip opportunities, and a look at which Singapore bank currently offers the best value, along with REIT picks and hidden income gems.
We examine AI chipmaker Nvidia’s stellar quarterly results that counter bubble fears, alongside Singapore’s ambitious equities market overhaul and a groundbreaking SGX-Nasdaq dual listing bridge.
If you know what you want, you have won half the battle.
Find out which three lesser-known Singapore dividend stocks can strengthen, diversify and boost your retirement income beyond the traditional STI names.
These 5 REITs could potentially provide investors with stable monthly income
Chasing high yields can be tempting, but it often leads to painful losses. Here are three common mistakes income investors make and how to avoid them.
Popular
Income investors should focus on the stability and sustainability of the dividends they receive from companies; in this article, we take a look at three Singapore names that have maintained reliable pay-outs for more than a decade.
From a record-breaking AI chip deal to a historic leadership milestone and major real estate moves, this week’s market highlights showcase how innovation, influence, and investment continue to shape opportunities for investors in 2025.
October brings fresh opportunities for dividend investors as we look at three Singapore REITs that stand out in a changing market landscape.
Singapore’s push towards net-zero by 2050 is opening up fresh opportunities. Discover three Singapore-listed companies that could benefit from the nation’s green transition.
Stocks
This investing mistake looks harmless at first, but has lasting consequences for many Singapore investors.
These three Singapore stocks combine fortress balance sheets with yields above 5%.
These five stocks should allow you to sleep soundly at night while collecting attractive dividends.
With a solid yield now, investors ask: can CapitaLand Integrated Commercial Trust (CICT) sustain its payout through 2026 and beyond?
Getting Started
Will technology stocks remain relevant in the brave new world?
The world faces a different kind of problem aside from the pandemic, but one that can be tackled with pharmaceuticals.
With a potential rocky and unsteady recovery post-COVID-19, here’s how you can locate stocks that will do well.
As enticing and appealing as cash might be, the problem is that there is a cost associated with keeping it.